全文获取类型
收费全文 | 7511篇 |
免费 | 449篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 41篇 |
儿科学 | 130篇 |
妇产科学 | 221篇 |
基础医学 | 771篇 |
口腔科学 | 64篇 |
临床医学 | 730篇 |
内科学 | 1381篇 |
皮肤病学 | 96篇 |
神经病学 | 946篇 |
特种医学 | 327篇 |
外科学 | 1086篇 |
综合类 | 15篇 |
一般理论 | 9篇 |
预防医学 | 704篇 |
眼科学 | 155篇 |
药学 | 215篇 |
肿瘤学 | 1080篇 |
出版年
2024年 | 12篇 |
2023年 | 363篇 |
2022年 | 529篇 |
2021年 | 519篇 |
2020年 | 626篇 |
2019年 | 384篇 |
2018年 | 403篇 |
2017年 | 388篇 |
2016年 | 406篇 |
2015年 | 351篇 |
2014年 | 762篇 |
2013年 | 560篇 |
2012年 | 380篇 |
2011年 | 362篇 |
2010年 | 484篇 |
2009年 | 419篇 |
2008年 | 147篇 |
2007年 | 133篇 |
2006年 | 113篇 |
2005年 | 69篇 |
2004年 | 37篇 |
2003年 | 58篇 |
2002年 | 46篇 |
2001年 | 45篇 |
2000年 | 30篇 |
1999年 | 55篇 |
1998年 | 41篇 |
1997年 | 31篇 |
1996年 | 38篇 |
1995年 | 38篇 |
1994年 | 31篇 |
1993年 | 21篇 |
1992年 | 10篇 |
1991年 | 7篇 |
1990年 | 13篇 |
1989年 | 10篇 |
1988年 | 9篇 |
1987年 | 15篇 |
1986年 | 20篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1978年 | 1篇 |
1977年 | 2篇 |
1976年 | 1篇 |
排序方式: 共有7971条查询结果,搜索用时 31 毫秒
121.
《Neuromuscular disorders : NMD》2014,24(12):1054-1062
This study describes the swallowing function of patients with myotonic dystrophy type 1 (DM1) and the effect of bolus consistency on swallowing in this group. The aim of the study is twofold: (a) to identify which (and to what extent) swallowing variables change for DM1 patients relative to healthy control subjects and (b) to examine whether the degree of oropharyngeal dysphagia is associated with disease severity. Forty-five consecutive DM1 patients and ten healthy subjects underwent a swallowing assessment, at Maastricht University medical Center in the Netherlands. The assessment included a standardized fiberoptic endoscopic evaluation of swallowing (FEES) protocol using different bolus consistencies. Clinical severity of the disease was assessed using the muscular impairment rating scale (MIRS). Significant differences were found between patients and controls for all FEES variables. The magnitude of these differences depended on the bolus consistency. The odds of a more pathological swallowing outcome increased significantly with higher MIRS levels. In conclusion, swallowing function is found to be significantly altered in DM1 patients. The results emphasize the importance of conducting a detailed swallowing assessment in all patients, even those with mild muscle weakness. 相似文献
122.
Adoptive transfer of regulatory T (Treg) cells have been employed effectively for suppression of several animal models for autoimmune diseases. In order to employ Treg cell therapy in patients, it is necessary to generate Treg cells from the patient's own cells (autologous) that would be able to suppress effectively the disease in vivo, upon their reintroduction to the patient. Towards this objective, we report in the present study on a protocol for a successful immune-regulation of experimental autoimmune myasthenia gravis (EAMG) by ex vivo – generated autologous Treg cells. For this protocol bone marrow (BM) cells, are first cultured in the presence of GM-CSF, giving rise to a population of CD11c+MHCII+CD45RA+CD8– DCs (BMDCs). Splenic CD4+ T cells are then co-cultured with the differentiated BM cells and expand to 90% of Foxp3+ Treg cells. In vitro assay exhibits a similar dose dependent manner in the suppression of T effector cells proliferation between Treg cells obtained from either healthy or sick donors. In addition, both Treg cells inhibit similarly the secretion of IFN-γ from activated splenocytes. Administration of 1 × 106 ex-vivo generated Treg cells, I.V, to EAMG rats, modulates the disease following a single treatment, given 3 days or 3 weeks after disease induction. Similar disease inhibition was achieved when CD4 cells were taken from either healthy or sick donors. The disease suppression was accompanied by reduced levels of total AChR specific antibodies in the serum. Moreover, due to the polyclonality of the described Treg cell, we have examined whether this treatment approach could be also employed for the treatment of other autoimmune diseases involving Treg cells. Indeed, we demonstrated that the ex-vivo generated autologous Treg cells suppress Adjuvant Arthritis (AA) in rats.This study opens the way for the application of induced autologous Treg cell therapy for myasthenia gravis, as well as for other human autoimmune diseases involving Treg cells. 相似文献
123.
《Annals of oncology》2021,32(11):1442-1443
124.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2019,31(11):779-788
Transplant recipients have a significantly higher risk of developing non-melanoma skin cancers compared with the general population and squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the most common post-transplant malignancies. Although in the general population BCC outnumbers SCC 4:1, in transplant patients this ratio is reversed and SCC is more common, with a 65- to 250-fold increased incidence. As patients in immunosuppressed states are living longer after transplants, the incidence of skin cancer in this population continues to increase. The skin cancers in transplant patients also tend to be more aggressive, with higher morbidity and mortality. Preventive strategies play an important role in transplant recipients given their increased frequency of developing both premalignant and malignant skin lesions. Sun protection and regular skin cancer screening are critical. In addition, chemoprophylaxis with systemic retinoids, nicotinamide and capecitabine can significantly reduce the development of new skin cancers. Topical 5-fluorouracil, imiquimod, photodynamic therapy and cyclooxygenase inhibitors have all been investigated in transplant patients for the treatment of field cancerisation. Adjusting the immunosuppressive regimen is also an important adjuvant therapeutic strategy for managing skin cancers in transplant recipients and requires integrated multidisciplinary care with the entire transplant team. This article reviews the epidemiology of non-melanoma skin cancer in transplant patients, discusses the prevention strategies and highlights the management and treatment strategies of both field cancerisation and non-melanoma skin cancers. 相似文献
125.
《Journal of Crohn's and Colitis》2012,6(1):112-115
Colorectal small cell carcinomas (SCCs) are rare tumors and are infrequently associated with ulcerative colitis (UC). We report a case of primary rectal SCC combined with adenocarcinoma arising in left-sided UC. Immunohistochemically, tumor cells were positive for chromogranin A, synaptophysin, and CD56 in the SCC but not in the adenocarcinoma. The patient simultaneously developed multiple lesions of adenocarcinoma and high-grade dysplasia in the sigmoid colon and rectum. To elucidate whether SCC might evolve from multipotential cells in dysplasia and/or adenocarcinoma, we examined the mutational status of TP53 and KRAS. The same clonality of these lesions including SCC was confirmed by the presence of an identical single nucleotide point mutation in TP53. KRAS mutation was not observed in these lesions. Thus, these lesions seem to have developed from the same origin. Long-standing inflammation leading to dysplasia might be responsible for the development of some SCCs in UC particularly when they are combined with dysplasia and/or adenocarcinoma. 相似文献
126.
127.
128.
129.
130.